These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19756158)

  • 1. Predicting positive p53 cancer rescue regions using Most Informative Positive (MIP) active learning.
    Danziger SA; Baronio R; Ho L; Hall L; Salmon K; Hatfield GW; Kaiser P; Lathrop RH
    PLoS Comput Biol; 2009 Sep; 5(9):e1000498. PubMed ID: 19756158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of cancer rescue p53 mutants in silico using Naïve Bayes learning methodology.
    Ramani RG; Jacob SG
    Protein Pept Lett; 2013 Nov; 20(11):1280-91. PubMed ID: 23772609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants.
    Danziger SA; Zeng J; Wang Y; Brachmann RK; Lathrop RH
    Bioinformatics; 2007 Jul; 23(13):i104-14. PubMed ID: 17646286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants.
    Danziger SA; Swamidass SJ; Zeng J; Dearth LR; Lu Q; Chen JH; Cheng J; Hoang VP; Saigo H; Luo R; Baldi P; Brachmann RK; Lathrop RH
    IEEE/ACM Trans Comput Biol Bioinform; 2006; 3(2):114-25. PubMed ID: 17048398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting transcriptional activity of multiple site p53 mutants based on hybrid properties.
    Huang T; Niu S; Xu Z; Huang Y; Kong X; Cai YD; Chou KC
    PLoS One; 2011; 6(8):e22940. PubMed ID: 21857971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
    Inga A; Resnick MA
    Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in silico algorithm for identifying stabilizing pockets in proteins: test case, the Y220C mutant of the p53 tumor suppressor protein.
    Bromley D; Bauer MR; Fersht AR; Daggett V
    Protein Eng Des Sel; 2016 Sep; 29(9):377-90. PubMed ID: 27503952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the
    Chitrala KN; Nagarkatti M; Nagarkatti P; Yeguvapalli S
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensemble-based computational approach discriminates functional activity of p53 cancer and rescue mutants.
    Demir Ö; Baronio R; Salehi F; Wassman CD; Hall L; Hatfield GW; Chamberlin R; Kaiser P; Lathrop RH; Amaro RE
    PLoS Comput Biol; 2011 Oct; 7(10):e1002238. PubMed ID: 22028641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting the transactivation activity of p53 missense mutants using a four-body potential score derived from Delaunay tessellations.
    Mathe E; Olivier M; Kato S; Ishioka C; Vaisman I; Hainaut P
    Hum Mutat; 2006 Feb; 27(2):163-72. PubMed ID: 16395672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and Function of p53-DNA Complexes with Inactivation and Rescue Mutations: A Molecular Dynamics Simulation Study.
    Kamaraj B; Bogaerts A
    PLoS One; 2015; 10(8):e0134638. PubMed ID: 26244575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel p53 mutant found in iatrogenic urothelial cancers is dysfunctional and can be rescued by a second-site global suppressor mutation.
    Odell AF; Odell LR; Askham JM; Alogheli H; Ponnambalam S; Hollstein M
    J Biol Chem; 2013 Jun; 288(23):16704-16714. PubMed ID: 23612969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of P53 mutants (multiple sites) transcriptional activity based on structural (2D&3D) properties.
    Ramani RG; Jacob SG
    PLoS One; 2013; 8(2):e55401. PubMed ID: 23468845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of restoring sequence-specific DNA binding and transactivation to mutant p53 by suppressor mutations.
    Suad O; Rozenberg H; Brosh R; Diskin-Posner Y; Kessler N; Shimon LJ; Frolow F; Liran A; Rotter V; Shakked Z
    J Mol Biol; 2009 Jan; 385(1):249-65. PubMed ID: 18996393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common gain of function of p53 cancer mutants in inducing genetic instability.
    Liu DP; Song H; Xu Y
    Oncogene; 2010 Feb; 29(7):949-56. PubMed ID: 19881536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
    Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL
    Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. QM-MM simulations on p53-DNA complex: a study of hot spot and rescue mutants.
    Koulgi S; Achalere A; Sharma N; Sonavane U; Joshi R
    J Mol Model; 2013 Dec; 19(12):5545-59. PubMed ID: 24253321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties.
    Song H; Wu J; Tang Y; Dai Y; Xiang X; Li Y; Wu L; Wu J; Liang Y; Xing Y; Yan N; Li Y; Wang Z; Xiao S; Li J; Zheng D; Chen X; Fang H; Ye C; Ma Y; Wu Y; Wu W; Li J; Zhang S; Lu M
    Sci Transl Med; 2023 Apr; 15(690):eabn9155. PubMed ID: 37018419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
    Aggarwal M; Saxena R; Asif N; Sinclair E; Tan J; Cruz I; Berry D; Kallakury B; Pham Q; Wang TTY; Chung FL
    J Exp Clin Cancer Res; 2019 Jul; 38(1):307. PubMed ID: 31307507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay.
    Duddy PM; Hanby AM; Barnes DM; Camplejohn RS
    J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.